Φορτώνει......
Proteasome inhibitors suppress the protein expression of mutant p53
Tumor suppressor p53 is one of the most frequently mutated genes in cancer, with almost 50% of all types of cancer expressing a mutant form of p53. p53 transactivates the expression of its primary negative regulator, HDM2. HDM2 is a ubiquitin ligase, which initiates the proteasomal degradation of p5...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cell Cycle |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2014
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613555/ https://ncbi.nlm.nih.gov/pubmed/25485499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15384101.2014.950132 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|